In The News Posted June 19, 2019 Share Posted June 19, 2019 GERMANTOWN, Md., June 19, 2019 /PRNewswire/ -- SERAXIS Inc., the developer of SR-01, a cell therapy for insulin-dependent diabetes, today announces signing a research collaboration agreement with Wake Forest Baptist Health to further build on SERAXIS existing diabetes program. SERAXIS... View the full article Link to comment Share on other sites More sharing options...
Recommended Posts
Archived
This topic is now archived and is closed to further replies.